CSE Bulletin: Consolidation - Biocure Technology Inc. (CURE.X)

Toronto, Ontario--(Newsfile Corp. - le 23 octobre/October 2024) - Biocure Technology Inc. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every nine (9) pre-consolidated common shares.

As a result, the outstanding shares of the company will be reduced to approximately 10,444,504 common shares.

The name and symbol will not change.

Please note that all open orders will be canceled at the close of business on October 25, 2024. Dealers are reminded to re-enter their orders taking into account the share consolidation.

_________________________________

Biocure Technology Inc. a annoncé une consolidation de ses actions ordinaires émises et en circulation sur la base d'une (1) action ordinaire post-consolidée pour neuf (9) actions ordinaires pré-consolidées.

En conséquence, les actions en circulation de la société seront réduites à environ 10 444 504 actions ordinaires.

Le nom et le symbole ne changeront pas.

Veuillez noter que toutes les commandes ouvertes seront annulées à la fermeture des bureaux le 25 octobre 2024. Il est rappelé aux concessionnaires de ré-saisir leurs commandes en tenant compte de la consolidation des actions.

You May Also Be Interested In

• Stripe, Advent In Talks To Buy Paypal - WSJ
• Simply Solventless Provides Update on Filing of 2025 Annual Financial Statements and Related Management's Discussion and Analysis and Management Cease Trade Order
• New Mexico gas pipeline for Oracle data center delayed to 2027